CYCN
Cyclerion Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.52
+0.00%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$50
- Revenue estimate
- $550.0K
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$7.10
- Revenue actual
- —
- Revenue estimate
- $1.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +82.6%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$7.10 | -$0.41 | Beat 94.23% | — |
| May 12, 2026 | -$17 | -$0.76 | Beat 95.58% | — |
| Mar 30, 2026 | -$0.38 | -$0.19 | Beat 50.00% | $1.0M |
| Nov 12, 2025 | — | -$0.30 | — | $875.0K |
| Mar 4, 2025 | — | $0.22 | — | $1.8M |
| Nov 14, 2024 | — | -$0.29 | — | $194.0K |
| Mar 5, 2024 | -$7.40 | -$0.68 | Beat 90.75% | — |
| Nov 13, 2023 | -$6.40 | -$0.93 | Beat 85.47% | — |
| Jul 28, 2023 | -$5.60 | -$1.83 | Beat 67.32% | — |
| May 11, 2023 | -$6.00 | -$3.20 | Beat 46.67% | — |
| Mar 22, 2023 | -$5.80 | -$3.20 | Beat 44.83% | $1.6M |
| Nov 3, 2022 | -$7.00 | -$4.80 | Beat 31.43% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026